All In MedTech

Company

Orthofix

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

Orthofix is on our public-company list (ticker OFIX). Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements.

Public

Listed

OFIX

Nasdaq · Orthofix Medical Inc.

Public float

$440M

Value of shares held by non-insiders on Jun 30, 2025

Revenue

$822M

Fiscal year ending Dec 31, 2025

Net income

-$92.2M

Fiscal year ending Dec 31, 2025

R&D spending

$65.8M

Fiscal year ending Dec 31, 2025

Cash

$86.3M

As of Sep 30, 2026

Long-term debt

$222M

As of Sep 30, 2026

Shares outstanding

40.8M

As of Nov 5, 2026

Capital raised as a public company

Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.

YearIPOStock soldLong-term debtConvertible debt
2025–$5.9M––
2024–$6.3M––
2023–$5.1M––
2022–$4.3M––
2021–$8.8M––

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

The investor database is part of the paid tier

For Orthofix we have 4 shareholders with 5% or more.

It is included for signed-in readers who have credit, along with the daily news digest. Credit is also what pays for AI device summaries.

Latest FDA decisions

The 8 newest of 69 since 2015.

Search the Clearance Tracker

66 more FDA decisions with a free account

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar

18 more trials with a free account

Reports received

126

Received Nov 1, 2025 to Nov 20, 2026

Malfunction reports

37

29% of reports

Injury reports

89

71% of reports

Death reports

0

0.0% of reports

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 231000
Jan 243300
Feb 249400
Mar 240200
Apr 241500
May 2411300
Jun 244600
Jul 242600
Aug 241400
Sep 2411200
Oct 244500
Nov 244500
Dec 243700
Jan 250300
Feb 257400
Mar 2531300
Apr 251500
May 252300
Jun 251900
Jul 251300
Aug 252600
Sep 250300
Oct 2510200
Nov 255400
Dec 2561000
Jan 261500
Feb 260700
Mar 265700
Apr 2671400
May 2611100
Jun 263700
Jul 262500
Aug 266700
Sep 261600
Oct 260600
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

7 more in this ranking with a free account

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

7 more in this ranking with a free account

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

87 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.